The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

• প্রধান লেখক: Jerold Jeyaratnam (Author), Nienke M. ter Haar (Author), Helen J. Lachmann (Author), Ozgur Kasapcopur (Author), Amanda K. Ombrello (Author), Donato Rigante (Author), Fatma Dedeoglu (Author), Ezgi H. Baris (Author), Sebastiaan J. Vastert (Author), Nico M. Wulffraat (Author), Joost Frenkel (Author)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2018-03-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Withholding live-attenuated vaccines in patients using interleukin (IL)-1 or IL-6 blocking agents is recommended by guidelines for both pediatric and adult rheumatic diseases, since there is a risk of infection in an immune suppressed host. However, this has never been studied. T...